Federico Corelli

Biography

Federico Corelli was born in Pescara, Italy, in 1953. He graduated in Medicinal Chemistry at the University of Rome La Sapienza in 1977 under the supervision of Prof. R. Giuliano. He joined Artico's group at the same University in 1980 and was appointed Assistant Professor in 1983. In 1987 he moved as Associate Professor of Medicinal Chemistry to the University of Siena, where he was appointed Full Professor since July 1st, 2000. Dean of the Faculty of Pharmacy since November 1st, 2003 to October 31, 2009. He served as the Chairman for two cycles of the Ph.D. School in Pharmaceutical Sciences of the University of Siena and in 2007 was appointed in the Scientific Committee of the Ph.D. School in Science of Drugs and Bioactive Substances of the University of Pisa. He was in the scientific/organizing board of twenty national and international scientific conferences. In 2008-2012, he was the director of the Workshop in Synthetic Metodologies in Medicinal Chemistry of the Division of Medicinal Chemistry of the Italian Chemical Society. Since January 1st, 2013 is a member of the Steering Committee of the Division of Medicinal Chemistry of the Italian Chemical Society. He’s a member of the Editorial Advisory Board of Central Nervous System Agents in Medicinal Chemistry and acted as a reviewer for a number of international scientific journals. His research interests include the synthesis of biologically active compounds, especially antiviral, antibacterial and antifungal compounds, CNS and antitumor agents. His current research activity mainly deals with the synthesis and pharmacological evaluation of new selective ligands of cannabinoid receptors and allosteric modulators of GABAB receptor. He is the author of 8 patent applications, 198 scientific papers, 8 chapters in books, more than 90 oral/poster communications in international and national meetings. He has also been editor of a book.

Research Interest

His research interests include the synthesis of biologically active compounds, especially antiviral, antibacterial and antifungal compounds, CNS and antitumor agents. His current research activity mainly deals with the synthesis and pharmacological evaluation of new selective ligands of cannabinoid receptors and allosteric modulators of GABAB receptor.